loader image

Oncology Clinical Trials

Join Our Mission to Fight Cancer

Access to novel treatment therapies

The opportunity to be part of medical innovations

Eligible for compensation for owner and referrer

Current Clinical Trials

Squamous Cell Carcinoma

Novel Intralesional chemotherapy for treatment of SCC

Purpose: Investigate a potential new treatment to stop squamous cell carcinoma progression and/or reduce evidence of disease.

How it works: Over the course of approximately 4 months, the patient will present for 11 visits to MVMC that will include physical examinations, lab work, and the study treatment.

Clients will pay for initial consultation then the study covers all additional related costs, including:

  • Physical exams
  • Lab work
  • Study treatment

Biomarker Study in Dogs with Lymphoma, Hemangiosarcoma, and Melanoma

Purpose: Partnering with IDEXX to identify biomarkers in the blood that will aid in research to develop more sensitive cancer diagnostic tests.

How it works: Refer for oncology consultation. A 5-10ml sample of whole blood will be collected and submited to the lab. Client will receive $50 credit on their consultation invoice and a $50 gift certificate from IDEXX.

Osteosarcoma

Autologous Canine Cancer Vaccine with Checkpoint Inhibitor for Treatment of Osteosarcoma

Purpose: Determine if combining surgery with the experimental treatment results in increased survival vs. surgery and chemotherapy alone.

How it works:
There will be two treatments groups:

  1. Surgery/amputation + experimental immunotherapy
  2. Surgery/amputation + chemotherapy (carboplatin)

Owner is financially responsible for all screening (consult, lab work, radiographs, abdominal ultrasound+/- cytology at DVM discretion) ~$2300.

Owner’s will receive a $1500 stipend toward amputation.

When enrolled into the study the participant will be enrolled into one of the groups carboplatin or immunotherapy. All treatments and monitoring fees will be covered by study for 6 months.

If chemotherapy fails for the patient, they will be offered the experimental immunotherapy at no cost.

To refer a patient, email oncology@mvmc.vet

For more information and to refer a client, call (207) 885-1290